6Inaba T, Yagyu H, Itabashi N, et al. Cholesterol reduction and atherosclerosis inhibition by bezafibrate in lowdensity lipoprotein receptor knockout mice[ J]. Hypertens Res, 2008, 31 (5):999-1005. 被引量：1
7Hrebicek J. PPARs: the role in glucose and lipid homeostasis, insulin resistance and atherosclerosis [ J]. Cesk Fysiol, 2004, 53( 1 ) : 4-16. 被引量：1
8Tenenbaum A, Motro M, Fisman EZ. Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons [ J ]. Cardiovasc Diabetol, 2005, 16(4) :14. 被引量：1
9Nagasawa T, Inada Y, Nakano S, et al. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet[J]. EurJ Pharmacol, 2006, 536(1-2) :182-191. 被引量：1
10Hiuge A, Tenenbaum A, Maeda N,et al. Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level [ J J. Arterioscler Thromb Vasc Biol, 2007, 27(3):635-641. 被引量：1
